Acadian Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-280
| Closed | -$14K | – | 1747 |
|
|
2024
Q3 | $14K | Buy |
+280
| New | +$14K | ﹤0.01% | 2016 |
|
|
2018
Q1 | – | Sell |
-84,158
| Closed | -$687K | – | 1700 |
|
|
2017
Q4 | $687K | Sell |
84,158
-314,919
| -79% | -$2.57M | ﹤0.01% | 761 |
|
|
2017
Q3 | $5.79M | Sell |
399,077
-367,186
| -48% | -$5.32M | 0.03% | 350 |
|
|
2017
Q2 | $9.27M | Buy |
766,263
+431,457
| +129% | +$5.22M | 0.04% | 291 |
|
|
2017
Q1 | $4.3M | Buy |
+334,806
| New | +$4.3M | 0.02% | 442 |
|
|
2016
Q3 | – | Sell |
-334,284
| Closed | -$3.17M | – | 1444 |
|
|
2016
Q2 | $3.17M | Sell |
334,284
-889,162
| -73% | -$8.44M | 0.02% | 452 |
|
|
2016
Q1 | $8.62M | Buy |
1,223,446
+53,134
| +5% | +$375K | 0.04% | 295 |
|
|
2015
Q4 | $12.2M | Buy |
1,170,312
+1,079,774
| +1,193% | +$11.3M | 0.06% | 267 |
|
|
2015
Q3 | $606K | Sell |
90,538
-40,276
| -31% | -$270K | ﹤0.01% | 754 |
|
|
2015
Q2 | $879K | Buy |
130,814
+103,813
| +384% | +$698K | ﹤0.01% | 703 |
|
|
2015
Q1 | $183K | Buy |
+27,001
| New | +$183K | ﹤0.01% | 934 |
|
|
2013
Q4 | – | Sell |
-1,118
| Closed | -$8K | – | 1052 |
|
|
2013
Q3 | $8K | Buy |
+1,118
| New | +$8K | ﹤0.01% | 945 |
|